MIST (Milestone Pharmaceuticals) Other Current Liabilities: $2.07 Mil (As of Mar. 2026)


MIST Milestone Pharmaceuticals Inc MIST
26 GF Score
Price $1.32
! 6 Warning Signs
View Full Analysis

What is Milestone Pharmaceuticals Other Current Liabilities?

Milestone Pharmaceuticals MIST -0.38% 26 Other Current Liabilities is $2.07 Mil as of Mar. 2026. GuruFocus rates MIST with a GF Score™ of 26/100. The stock has 6 warning signs investors should review.

Milestone Pharmaceuticals's other current liabilities for the quarter that ended in Mar. 2026 was $2.07 Mil.

Milestone Pharmaceuticals's quarterly other current liabilities increased from Sep. 2025 ($2.41 Mil) to Dec. 2025 ($2.50 Mil) but then declined from Dec. 2025 ($2.50 Mil) to Mar. 2026 ($2.07 Mil).

Milestone Pharmaceuticals's annual other current liabilities increased from Dec. 2023 ($0.71 Mil) to Dec. 2024 ($2.50 Mil) but then stayed the same from Dec. 2024 ($2.50 Mil) to Dec. 2025 ($2.50 Mil).

Milestone Pharmaceuticals Other Current Liabilities Related Terms

Milestone Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Milestone Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Pharmaceuticals Other Current Liabilities Chart

Milestone Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 1.46 2.57 0.71 2.50 2.50

Milestone Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 2.03 2.41 2.50 2.07
MIST
26GF Score
Milestone Pharmaceuticals Inc MIST
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milestone Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $2.07 Mil mean?
Milestone Pharmaceuticals (MIST) has a Other Current Liabilities of $2.07 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Milestone Pharmaceuticals.
Is Milestone Pharmaceuticals' Other Current Liabilities too high?
Milestone Pharmaceuticals' current Other Current Liabilities is $2.07 Mil. Overall, Milestone Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Milestone Pharmaceuticals' Other Current Liabilities compare to TNYA and TLSA?
Milestone Pharmaceuticals' Other Current Liabilities of $2.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Milestone Pharmaceuticals. Milestone Pharmaceuticals's current Other Current Liabilities is $2.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Pharmaceuticals stock overvalued right now?
Milestone Pharmaceuticals (MIST) has a current Other Current Liabilities of $2.07 Mil. The current Other Current Liabilities is $2.07 Mil. Milestone Pharmaceuticals' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current Other Current Liabilities is $2.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Milestone Pharmaceuticals Business Description

Address 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
26GF Score

Get the complete analysis for MIST

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.32
Price